cbdMD Inc

cbdMD, Inc. engages in the business of operating cannabidiol brands such as Paw cannabidiol and cbdMD botanicals. Its product categories include CBD tinctures, gummies, topical, and bath bombs. The company was founded by Caryn Dunayer on March 17, 2015 and is headquartered in Charlotte, NC.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

cbdMD, Inc. engages in the business of operating cannabidiol brands such as Paw cannabidiol and cbdMD botanicals. Its product categories include CBD tinctures, gummies, topical, and bath bombs. The company was founded on March 17, 2015 and is headquartered in Charlotte, NC.

CHARLOTTE, N.C.--(BUSINESS WIRE)--cbdMD, Inc. (NYSE American: YCBD, YCBDpA), (the “Company”) announced today that it has received validation of its Novel Food application from the United Kingdom's Food Standards Agency (“FSA”) (the “Validation”) for its natural plant-based CBD formulation and is now the first American CBD brand to achieve this significant milestone. The Company also anticipates validation of its application to the European Food Safety Authority in the coming weeks. Over 800 com

cbdMD Becomes First American CBD Brand to Receive Validation by the United Kingdom Food Standards Agency

cbdMD's (YCBD) CEO Marty Sumichrast on Q1 2022 Results - Earnings Call Transcript

CHARLOTTE, N.C.--(BUSINESS WIRE)--cbdMD, Inc. (NYSE American: YCBD, YCBDpA), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of three of the leading CBD brands -- its flagship brand cbdMD, its animal health brand Paw CBD and its beauty and skincare brand cbdMD Botanicals, -- today we announced our financial results for December 31, 2021, the first quarter of our fiscal year ended September 30, 2022 and the third full year of operations with our cbd

cbdMD Completes Third Full Year Results; Total Brands Sales of $118.7 Million Exceeds Initial Earn Out Target

Wellness CBD company cbdMD, Inc. YCBD announced that it is the first and only CBD company to earn the highly respected designation of NSF Certified for Sport, which opens the door to acceptance by major sports leagues in the USA and internationally. The company's award-winning, patent-pending proprietary broad spectrum hemp extract blend containing CBD, CBG and CBN passed the rigorous testing standards set forth by NSF International.

cbdMD Becomes The First CBD Company With NSF International's Certified For Sport Certification

CHARLOTTE, N.C.--(BUSINESS WIRE)--cbdMD, Inc. (NYSE American: YCBD, YCBDpA), one of the world's leading and most highly trusted and recognized health & wellness CBD companies, today announced that it is the first and only CBD company to earn the highly respected designation of NSF Certified for Sport,® which opens the door to acceptance by major sports leagues in the USA and internationally. The Company's award-winning, patent-pending proprietary broad spectrum hemp extract blend containing

cbdMD Becomes the First CBD Company to Earn Prestigious NSF International's Certified for Sport® Certification

cbdMD, Inc. YCBD recently launched a new line of wellness gummies designed specifically for daily use. The current catalogue release includes Calming, ACV - apple cider vinegar - and Sleep-Aid wellness gummies, with numerous other formulations in the pipeline for development.

cbdMD Launches New Functional Gummies Line As Market Increases

CHARLOTTE, N.C.--(BUSINESS WIRE)--cbdMD, Inc. (NYSE American: YCBD, YCBDpA), one of the world's leading, and most highly trusted and recognized health & wellness CBD companies, announced today that it will host a conference call at 4:15 p.m., Eastern Time, on Thursday, February 10, 2022, to discuss the company's December 31, 2021 first quarter financial results and business progress. CONFERENCE CALL DETAILS Thursday, February 10, 2022, 4:15 p.m. Eastern Time Domestic: 888-506-0062 Internati

cbdMD, Inc. To Host Conference Call To Discuss December 31, 2021, First Quarter Results

Aurora Cannabis

Agrify

Flora Growth Corp

MedMen Enterprises Inc.

Flora Growth Expands Product Distribution Through Walmart.com and Coppel in Mexico $FLGC Bad News for commercial cannabis sales in Virginia?

The Cannabis Investment Pick For 2022? Cannabis Daily January 4, 2022

cbdMD, Inc. (NYSE:YCBD) announced its financial results on Friday  for the fourth quarter and fiscal year ended September 30. Based in Charlotte, North Carolina, the company's net sales hit a record of $44.5 million in fiscal 2021.

cbdMD Reports 6% YoY Increase To Record $44.5M In Net Sales In 2021

cbdMD, Inc. (YCBD) CEO Marty Sumichrast on Q4 2021 Results - Earnings Call Transcript

cbdMD (AMEX:YCBD) reported its Q4 earnings results on Friday, December 17, 2021 at 04:10 PM. Here's what investors need to know about the announcement.

cbdMD: Q4 Earnings Insights

CHARLOTTE, N.C.--(BUSINESS WIRE)--cbdMD, Inc. (NYSE American: YCBD, YCBDpA), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of three of the leading CBD brands -- its flagship brand cbdMD, its animal health brand Paw CBD and its beauty and skincare brand cbdMD Botanicals, -- today announced its financial results for the fourth quarter and fiscal year ended September 30, 2021. “Next week is the three-year anniversary of our company entering the CBD

cbdMD Reports Fiscal Year Net Sales Increased 6.2% To Record $44.5 Million

CHARLOTTE, N.C.--(BUSINESS WIRE)--cbdMD, Inc. (NYSE American: YCBD, YCBDpA), one of the leading and most highly trusted and recognized CBD health & wellness companies, announced today that due to technical difficulties it will host its conference call at 4:15 p.m., Eastern Time, on Friday, December 17, 2021, to discuss the company's September 30, 2021 fourth quarter and fiscal year-end financial results and business progress. CONFERENCE CALL DETAILS Friday, December 17, 2021, 4:15 p.m. East

Due To Technical Difficulties, cbdMD, Inc. Moves Conference Call To Discuss September 30, 2021, Fourth Quarter and Fiscal Year Results To December 17, 2021 at 4:15 pm EST

cbdMD (AMEX:YCBD) is set to give its latest quarterly earnings report on Thursday, 2021-12-16. Here's what investors need to know before the announcement.

Preview: cbdMD's Earnings

Green Thumb Industries Inc.

High Tide

On today's episode of Cannabis Daily, our host Elliot Lane looks at buying the dip opportunities in Cannabis stocks. Public companies mentioned in today's episode:

Buy The Dip Opportunity For These California Companies — December 6, 2021

Canna-Global Acquisition Corp

Costco

IM Cannabis Corp

OLB Group

Tilray Brands

Welcome back to our weekly series,  Schaeffer's Cannabis Stock News Update , where we recap what happened in the world of marijuana stocks and look ahead to how the cannabis industry continues to shape up in 2021.

8 Cannabis Stocks on Fire As December Heats Up

CHARLOTTE, N.C.--(BUSINESS WIRE)--cbdMD, Inc. (NYSE American: YCBD, YCBDpA) (the “Company”), one of the leading, and most highly trusted and recognized cannabidiol (CBD) brands, announced today that it has commenced a preclinical human study with researchers at the University of South Carolina. The study will explore the effects of cbdMD's proprietary broad spectrum cannabinoid blend on sleep, mood, and pain in healthy subjects to further support the efficacy of the Company's products. The stud

cbdMD Therapeutics Announces Human Clinical Study In Collaboration With the University of South Carolina

CHARLOTTE, N.C.--(BUSINESS WIRE)--cbdMD, Inc. (NYSE American: YCBD, YCBDpA), one of the leading and most highly trusted and recognized CBD health & wellness companies, announced today that it will host a conference call at 4:15 p.m., Eastern Time, on Thursday, December 16, 2021, to discuss the company's September 30, 2021 fourth quarter and fiscal year end financial results and business progress. CONFERENCE CALL DETAILS Thursday, December 16, 2021, 4:15 p.m. Eastern Time    Domestic: 1-888-

cbdMD, Inc. To Host Conference Call To Discuss September 30, 2021 Fourth Quarter and Fiscal Year Results

cbdMD Inc. claims to be producing and distributing the purest hemp extract with CBD, CBG, and CBN without tetrahydrocannabinol. YCBD has the largest social media reach of all CBD competitors. In my view, if management continues to be that successful all over the internet, revenue will grow.

There Is More Than 50% Upside Potential In cbdMD Inc.

CHARLOTTE, N.C.--(BUSINESS WIRE)--cbdMD, Inc. (NYSE American: YCBD, YCBDpA), one of the leading, most highly trusted and best recognized CBD companies, announced the hiring of Dave Johnson as the Senior Vice President of Business Development. Mr. Johnson will be responsible for the Company's push into all major food, drug and mass merchandise (“FDM”) retailers in the U.S. as well as creating new avenues for greater product distribution. Mr. Johnson brings over 30 years of experience in the cons

cbdMD Announces Hiring of Consumer Goods Veteran Dave Johnson To Drive FDM Distribution Channel & Business Development

cbdMD, Inc. (NYSE:YCBD) has teamed up with Amazon.com Inc.'s (NASDAQ:AMZN) platform partner, Amify, to offer its CBD products within the Amazon marketplace. The terms of the deal were not disclosed.

Amazon's Amify Platform To Offer CBD Products Via Multi-Year Deal With cbdMD

The stock price of cbdMD, Inc. (NYSE American: YCBD) increased by 30.2% in the most recent trading session. This is why it happened.

cbdMD (YCBD) Stock: Why The Price Surged

cbdMD Inc (NYSE: YCBD) entered a multi-year exclusive agreement with Amify, an Amazon.com Inc (NASDAQ: AMZN) platform partner, to prepare for the inclusion of CBD products within the Amazon marketplace. The financial terms of the arrangement were not disclosed.

cbdMD Stock Jumps On Agreement With Amazon Platform Partner Amify

CbdMD (YCBD) stock is surging higher on Monday thanks to a deal with Amify to bring its CBD oil products to Amazon (AMZN). The post YCBD Stock: The Amify-Amazon Deal That Has cbdMD Shares Heading Higher Today appeared first on InvestorPlace.

YCBD Stock: The Amify-Amazon Deal That Has cbdMD Shares Heading Higher Today

CHARLOTTE, N.C.--(BUSINESS WIRE)--cbdMD, Inc. (NYSE American: YCBD, YCBDpA), one of the leading, most highly trusted and best recognized CBD companies, today announced their multi-year exclusive agreement with Amify, an Amazon.com, Inc. (NASDAQ:AMZN) platform partner, to prepare for the inclusion of CBD products within the Amazon marketplace. Amify, which specializes in Amazon go-to-market strategies, content creation and operational excellence, will act as cbdMD's exclusive CBD partner to laun

News for cbdMD Inc Stock (YCBD)